AtriCure, Inc. — Director's Dealing 2012

Sep 13, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2012-09-12

Reporting Person: Drachman David J (President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-09-12	Common Stock	M	20000	$5.5975	Acquired	166000	Direct
2012-09-12	Common Stock	S	20000	$7.04	Disposed	146000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-09-12	Stock Option (right to buy)	$5.5975	M	20000	Disposed	2020-02-12	Common Stock (20000)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $7.03 to $7.11 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: These options were granted on February 12, 2010 and are exercisable as to 25% of the shares on February 12, 2011 (one year from the date of grant) and the remaining 75% thereafter vesting and exercisable in equal monthly installments on the same day of the month over the following three years.